Ocugen, Inc. (OCGN)
0.8508
-0.02
(-2.61%)
USD |
NASDAQ |
Nov 13, 09:56
Ocugen Free Cash Flow (Quarterly) : -15.89M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -15.89M |
| June 30, 2026 | -12.22M |
| March 31, 2026 | -21.80M |
| December 31, 2025 | -14.00M |
| September 30, 2025 | -13.01M |
| June 30, 2025 | -10.77M |
| March 31, 2025 | -19.37M |
| December 31, 2024 | -10.38M |
| September 30, 2024 | -11.78M |
| June 30, 2024 | -10.42M |
| March 31, 2024 | -12.95M |
| December 31, 2023 | -14.02M |
| September 30, 2023 | -17.07M |
| June 30, 2023 | -21.58M |
| March 31, 2023 | -19.85M |
| December 31, 2022 | -18.94M |
| September 30, 2022 | -15.15M |
| June 30, 2022 | -15.16M |
| March 31, 2022 | -15.29M |
| December 31, 2021 | -12.87M |
| September 30, 2021 | -8.403M |
| June 30, 2021 | -22.06M |
| March 31, 2021 | -5.544M |
| December 31, 2020 | -4.534M |
| September 30, 2020 | -2.675M |
| Date | Value |
|---|---|
| June 30, 2020 | -3.068M |
| March 31, 2020 | -4.739M |
| December 31, 2019 | -8.764M |
| September 30, 2019 | -4.452M |
| June 30, 2019 | -3.355M |
| March 31, 2019 | -2.678M |
| December 31, 2018 | -2.786M |
| September 30, 2018 | -4.261M |
| June 30, 2018 | -6.692M |
| March 31, 2018 | 2.031M |
| December 31, 2017 | -4.463M |
| September 30, 2017 | -5.784M |
| June 30, 2017 | -5.667M |
| March 31, 2017 | -7.382M |
| December 31, 2016 | -5.896M |
| September 30, 2016 | -5.462M |
| June 30, 2016 | -6.825M |
| March 31, 2016 | -7.873M |
| December 31, 2015 | -7.128M |
| September 30, 2015 | -7.38M |
| June 30, 2015 | -7.871M |
| March 31, 2015 | -9.604M |
| December 31, 2014 | -6.889M |
| September 30, 2014 | -4.179M |
| June 30, 2014 | -5.519M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 6.716M |
| Nektar Therapeutics | -75.86M |
| Heron Therapeutics, Inc. | -0.896M |
| TG Therapeutics, Inc. | 44.94M |
| Tonix Pharmaceuticals Holding Corp. | -39.43M |